Neffy 1 mg now available for anaphylaxis in children aged 4 years and up
PKU and sepiapterin data with Suzanne Hollander, MS, RD, LDN
Expanding access to adolescent gender-affirming care in a changing legal landscape
RSV prophylaxis: Palivizumab, nirsevimab, and more